Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Sell
49
MLAB Quote, Financials, Valuation and Earnings
Last price:
$82.83
Seasonality move
:
9.26%
Day range:
$81.77 - $85.63
52-week range:
$55.45 - $155.12
Dividend yield:
0.77%
P/E ratio:
--
P/S ratio:
1.85x
P/B ratio:
2.56x
Volume:
51.4K
Avg. volume:
98.6K
1-year change:
-41.96%
Market cap:
$456.5M
Revenue:
$241M
EPS (TTM):
-$0.32
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$64.5M | $1.48 | 0.63% | 148.96% | $99.00 |
|
CGNX
Cognex Corp.
|
$228.8M | $0.19 | 5.89% | 38.93% | $48.05 |
|
FCUV
Focus Universal, Inc.
|
-- | -- | -- | -- | -- |
|
KEYS
Keysight Technologies, Inc.
|
$1.5B | $2.00 | 18.67% | 105.44% | $220.00 |
|
QRVO
Qorvo, Inc.
|
$905.4M | $1.37 | 4.32% | 312.06% | $98.78 |
|
SOTK
Sono-Tek Corp.
|
$5.6M | $0.02 | 9.37% | -3.85% | $6.38 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$82.66 | $99.00 | $456.5M | -- | $0.16 | 0.77% | 1.85x |
|
CGNX
Cognex Corp.
|
$39.76 | $48.05 | $6.7B | 61.41x | $0.09 | 0.82% | 6.96x |
|
FCUV
Focus Universal, Inc.
|
$0.78 | -- | $6.4M | -- | $0.00 | 0% | 14.76x |
|
KEYS
Keysight Technologies, Inc.
|
$212.94 | $220.00 | $36.6B | 43.59x | $0.00 | 0% | 6.86x |
|
QRVO
Qorvo, Inc.
|
$80.91 | $98.78 | $7.5B | 34.94x | $0.00 | 0% | 2.08x |
|
SOTK
Sono-Tek Corp.
|
$4.11 | $6.38 | $64.6M | 41.06x | $0.00 | 0% | 3.17x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
50.03% | 0.000 | 48.38% | 1.29x |
|
CGNX
Cognex Corp.
|
5.03% | 2.342 | 1.04% | 2.79x |
|
FCUV
Focus Universal, Inc.
|
10.5% | 1.695 | 0.09% | 1.05x |
|
KEYS
Keysight Technologies, Inc.
|
32.08% | 1.394 | 8.87% | 1.53x |
|
QRVO
Qorvo, Inc.
|
30.62% | 1.431 | 18.37% | 2.05x |
|
SOTK
Sono-Tek Corp.
|
-- | 0.297 | -- | 3.41x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$33M | $4.7M | -0.43% | -0.95% | 7.78% | $7.1M |
|
CGNX
Cognex Corp.
|
$187.3M | $57.8M | 6.96% | 7.32% | 20.86% | $86M |
|
FCUV
Focus Universal, Inc.
|
-$7.9K | -$1.2M | -245.73% | -254.53% | -4112.89% | -$1.1M |
|
KEYS
Keysight Technologies, Inc.
|
$876M | $186M | 10.95% | 15.9% | 13.11% | $187M |
|
QRVO
Qorvo, Inc.
|
$500.1M | $187.5M | 4.3% | 6.36% | 17.72% | $42.2M |
|
SOTK
Sono-Tek Corp.
|
$2.4M | $319K | 8.63% | 8.63% | 6.37% | $1.1M |
Mesa Laboratories, Inc. vs. Competitors
-
Which has Higher Returns MLAB or CGNX?
Cognex Corp. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 6.38%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Cognex Corp.'s return on equity of 7.32%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M CGNXCognex Corp.67.64% $0.10 $1.6B -
What do Analysts Say About MLAB or CGNX?
Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 19.77%. On the other hand Cognex Corp. has an analysts' consensus of $48.05 which suggests that it could grow by 20.85%. Given that Cognex Corp. has higher upside potential than Mesa Laboratories, Inc., analysts believe Cognex Corp. is more attractive than Mesa Laboratories, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 CGNXCognex Corp.10 6 0 -
Is MLAB or CGNX More Risky?
Mesa Laboratories, Inc. has a beta of 0.890, which suggesting that the stock is 10.974% less volatile than S&P 500. In comparison Cognex Corp. has a beta of 1.519, suggesting its more volatile than the S&P 500 by 51.873%.
-
Which is a Better Dividend Stock MLAB or CGNX?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.77%. Cognex Corp. offers a yield of 0.82% to investors and pays a quarterly dividend of $0.09 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Cognex Corp. pays out 49.59% of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Mesa Laboratories, Inc.'s is not.
-
Which has Better Financial Ratios MLAB or CGNX?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Cognex Corp. quarterly revenues of $276.9M. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Cognex Corp.'s net income of $17.7M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Cognex Corp.'s PE ratio is 61.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.85x versus 6.96x for Cognex Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.85x -- $60.7M $2.5M CGNXCognex Corp.6.96x 61.41x $276.9M $17.7M
-
Which has Higher Returns MLAB or FCUV?
Focus Universal, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of -4064.11%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Focus Universal, Inc.'s return on equity of -254.53%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M FCUVFocus Universal, Inc.-27.53% -$0.16 $195.3K -
What do Analysts Say About MLAB or FCUV?
Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 19.77%. On the other hand Focus Universal, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Mesa Laboratories, Inc. has higher upside potential than Focus Universal, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Focus Universal, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 FCUVFocus Universal, Inc.0 0 0 -
Is MLAB or FCUV More Risky?
Mesa Laboratories, Inc. has a beta of 0.890, which suggesting that the stock is 10.974% less volatile than S&P 500. In comparison Focus Universal, Inc. has a beta of 0.328, suggesting its less volatile than the S&P 500 by 67.17%.
-
Which is a Better Dividend Stock MLAB or FCUV?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.77%. Focus Universal, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Focus Universal, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or FCUV?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are larger than Focus Universal, Inc. quarterly revenues of $28.7K. Mesa Laboratories, Inc.'s net income of $2.5M is higher than Focus Universal, Inc.'s net income of -$1.2M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Focus Universal, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.85x versus 14.76x for Focus Universal, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.85x -- $60.7M $2.5M FCUVFocus Universal, Inc.14.76x -- $28.7K -$1.2M
-
Which has Higher Returns MLAB or KEYS?
Keysight Technologies, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 17.76%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Keysight Technologies, Inc.'s return on equity of 15.9%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M KEYSKeysight Technologies, Inc.61.73% $1.32 $8.7B -
What do Analysts Say About MLAB or KEYS?
Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 19.77%. On the other hand Keysight Technologies, Inc. has an analysts' consensus of $220.00 which suggests that it could grow by 3.32%. Given that Mesa Laboratories, Inc. has higher upside potential than Keysight Technologies, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than Keysight Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 KEYSKeysight Technologies, Inc.7 4 0 -
Is MLAB or KEYS More Risky?
Mesa Laboratories, Inc. has a beta of 0.890, which suggesting that the stock is 10.974% less volatile than S&P 500. In comparison Keysight Technologies, Inc. has a beta of 1.178, suggesting its more volatile than the S&P 500 by 17.764%.
-
Which is a Better Dividend Stock MLAB or KEYS?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.77%. Keysight Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Keysight Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or KEYS?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Keysight Technologies, Inc. quarterly revenues of $1.4B. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Keysight Technologies, Inc.'s net income of $252M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Keysight Technologies, Inc.'s PE ratio is 43.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.85x versus 6.86x for Keysight Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.85x -- $60.7M $2.5M KEYSKeysight Technologies, Inc.6.86x 43.59x $1.4B $252M
-
Which has Higher Returns MLAB or QRVO?
Qorvo, Inc. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 11.3%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Qorvo, Inc.'s return on equity of 6.36%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M QRVOQorvo, Inc.47.25% $1.28 $5.1B -
What do Analysts Say About MLAB or QRVO?
Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 19.77%. On the other hand Qorvo, Inc. has an analysts' consensus of $98.78 which suggests that it could grow by 22.08%. Given that Qorvo, Inc. has higher upside potential than Mesa Laboratories, Inc., analysts believe Qorvo, Inc. is more attractive than Mesa Laboratories, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 QRVOQorvo, Inc.3 19 0 -
Is MLAB or QRVO More Risky?
Mesa Laboratories, Inc. has a beta of 0.890, which suggesting that the stock is 10.974% less volatile than S&P 500. In comparison Qorvo, Inc. has a beta of 1.358, suggesting its more volatile than the S&P 500 by 35.778%.
-
Which is a Better Dividend Stock MLAB or QRVO?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.77%. Qorvo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Qorvo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or QRVO?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are smaller than Qorvo, Inc. quarterly revenues of $1.1B. Mesa Laboratories, Inc.'s net income of $2.5M is lower than Qorvo, Inc.'s net income of $119.6M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Qorvo, Inc.'s PE ratio is 34.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.85x versus 2.08x for Qorvo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.85x -- $60.7M $2.5M QRVOQorvo, Inc.2.08x 34.94x $1.1B $119.6M
-
Which has Higher Returns MLAB or SOTK?
Sono-Tek Corp. has a net margin of 4.08% compared to Mesa Laboratories, Inc.'s net margin of 6.79%. Mesa Laboratories, Inc.'s return on equity of -0.95% beat Sono-Tek Corp.'s return on equity of 8.63%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.54.3% $0.45 $357.1M SOTKSono-Tek Corp.47.34% $0.02 $19.1M -
What do Analysts Say About MLAB or SOTK?
Mesa Laboratories, Inc. has a consensus price target of $99.00, signalling upside risk potential of 19.77%. On the other hand Sono-Tek Corp. has an analysts' consensus of $6.38 which suggests that it could grow by 55.11%. Given that Sono-Tek Corp. has higher upside potential than Mesa Laboratories, Inc., analysts believe Sono-Tek Corp. is more attractive than Mesa Laboratories, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 SOTKSono-Tek Corp.1 1 0 -
Is MLAB or SOTK More Risky?
Mesa Laboratories, Inc. has a beta of 0.890, which suggesting that the stock is 10.974% less volatile than S&P 500. In comparison Sono-Tek Corp. has a beta of -0.304, suggesting its less volatile than the S&P 500 by 130.401%.
-
Which is a Better Dividend Stock MLAB or SOTK?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.77%. Sono-Tek Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Sono-Tek Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or SOTK?
Mesa Laboratories, Inc. quarterly revenues are $60.7M, which are larger than Sono-Tek Corp. quarterly revenues of $5M. Mesa Laboratories, Inc.'s net income of $2.5M is higher than Sono-Tek Corp.'s net income of $340K. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is -- while Sono-Tek Corp.'s PE ratio is 41.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 1.85x versus 3.17x for Sono-Tek Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.1.85x -- $60.7M $2.5M SOTKSono-Tek Corp.3.17x 41.06x $5M $340K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Will Data Centers Be In Space?
With demand for data centers seemingly growing by the day,…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
56
INTC alert for Jan 24
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
64
BNR alert for Jan 24
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Sell
19
APGE alert for Jan 24
Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.
